Search

everythinglearnresearchcommunity

for

Search:↓

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Early intervention for acute urinary retention can reduce costs and improve care.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Stag parts were historically used in medicine for various health issues.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

Older men with postoperative urinary retention are more likely to need future bladder procedures.

Finasteride use is linked to a lower risk of bladder cancer, especially in Caucasians and Hispanics.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Teaching men with simple bladder problems self-management skills can improve their symptoms and quality of life.

The IPP index is linked to storage symptoms and leftover urine, and may help manage urinary tract symptoms.

Minoxidil is better for female hair loss without hormonal issues, cyproterone acetate for those with; people with treated congenital heart disease have lower life quality; personality differs in types of infertility; oral terbinafine is best for toenail fungus; bladder training reduces incontinence; nurse clinics help with heart disease; weight loss improves body composition and liver disease; computer training cuts drug errors.

Biofeedback treatment for dysfunctional voiding in adults showed no symptom improvement.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

Urinary PSA could be an early marker for enlarged prostate.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride reduces urinary issues and surgery need in men with enlarged prostates by over 50%.

Lovastatin doesn't improve lower urinary tract symptoms treatment.